Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Poignard

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Immunity|May 19, 2016
Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose PatchDaniel T MacLeod, Nancy M Choi, Bryan Briney, et al.
Science (New York, N.Y.)|July 19, 2011
Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 bindingJohannes F Scheid, Hugo Mouquet, Beatrix Ueberheide, et al.
NPJ Vaccines|March 30, 2025
RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaquesHélène Letscher, Delphine Guilligay, Gregory Effantin, et al.
The Journal of Experimental Medicine|August 27, 2014
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaquesMasashi Shingai, Olivia K Donau, Ronald J Plishka, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2016
CXCL13 is a plasma biomarker of germinal center activityColin Havenar-Daughton, Madelene Lindqvist, Antje Heit, et al.
Science (New York, N.Y.)|September 5, 2009
Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine targetLaura M Walker, Sanjay K Phogat, Po-Ying Chan-Hui, et al.
Immunity|July 21, 2016
A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging GlycansDevin Sok, Matthias Pauthner, Bryan Briney, et al.
Journal of Virology|March 30, 2012
A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaquesBrian Moldt, Mami Shibata-Koyama, Eva G Rakasz, et al.
Plos Pathogens|May 10, 2013
Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycansJean-Philippe Julien, Devin Sok, Reza Khayat, et al.
Nature Communications|September 26, 2015
Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spikeJeong Hyun Lee, Daniel P Leaman, Arthur S Kim, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Immunity|May 19, 2016
Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose PatchDaniel T MacLeod, Nancy M Choi, Bryan Briney, et al.
Science (New York, N.Y.)|July 19, 2011
Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 bindingJohannes F Scheid, Hugo Mouquet, Beatrix Ueberheide, et al.
NPJ Vaccines|March 30, 2025
RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaquesHélène Letscher, Delphine Guilligay, Gregory Effantin, et al.
The Journal of Experimental Medicine|August 27, 2014
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaquesMasashi Shingai, Olivia K Donau, Ronald J Plishka, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2016
CXCL13 is a plasma biomarker of germinal center activityColin Havenar-Daughton, Madelene Lindqvist, Antje Heit, et al.
Science (New York, N.Y.)|September 5, 2009
Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine targetLaura M Walker, Sanjay K Phogat, Po-Ying Chan-Hui, et al.
Immunity|July 21, 2016
A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging GlycansDevin Sok, Matthias Pauthner, Bryan Briney, et al.
Journal of Virology|March 30, 2012
A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaquesBrian Moldt, Mami Shibata-Koyama, Eva G Rakasz, et al.
Plos Pathogens|May 10, 2013
Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycansJean-Philippe Julien, Devin Sok, Reza Khayat, et al.
Nature Communications|September 26, 2015
Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spikeJeong Hyun Lee, Daniel P Leaman, Arthur S Kim, et al.
Pageof 9